The Egyptian Drug Authority announced the start of activating the electronic payment service through the official website of the Authority, as part of its continuous efforts towards digital transformation and enhancing the efficiency of the services provided, which contributes to facilitating procedures and providing more effective service to customers.
Masuu Global is proud to highlight a significant milestone in international pharmaceutical collaboration: The BIO INN Laboratories of the Egyptian Drug Authority (EDA) have joined the General European OMCL Network (GEON), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), as an associated member. After Morocco, it is the second African official medicines control laboratory (OMCL) to become part of this network. The network is now counting 69 laboratories from 43 countries among its members.
Pharmacovigilance (PV) inspections are a crucial part of ensuring public health safety within the European Union (EU). These inspections are conducted by national competent authorities in cooperation with the European Medicines Agency (EMA) to verify that marketing authorisation holders (MAHs) are meeting their pharmacovigilance obligations.
Health Canada is making Structured Product Monograph (SPM) submissions in XML format mandatory starting July 18, 2025, for select drug applications. This move is part of Canada’s broader effort to modernize regulatory submissions and improve drug information accessibility.
When it comes to selling or distributing food products in the United States, compliance with the regulatory requirements of the U.S. Food and Drug Administration (USFDA) is essential. The FDA is responsible for ensuring the safety, labeling accuracy, and quality of food products to protect public health. Whether you’re a domestic food manufacturer or an importer, understanding and meeting these requirements is critical for market success.
